The cost of uterine cancer treatment can range from $9,920 to $14,750:
The doctor will determine the total treatment cost based on your needs and past treatments.
Turkey is a growing destination for uterine cancer treatment, with top clinics like Anadolu Medical Center, Dr. Esra Cabuk Comert's Clinic, and Medipol Mega University Hospital. Accredited by the Joint Commission International, these facilities provide advanced care. Anadolu Medical Center, affiliated with Johns Hopkins Hospital, is known for American treatment standards and high success rates. Dr. Esra Cabuk Comert's Clinic in Ankara specializes in gynecologic surgeries, while Medipol Mega University Hospital uses technologies like the Da Vinci Surgical System and CyberKnife.
Turkey offers innovative procedures such as robotic-assisted surgery, targeted therapy, immunotherapy, and brachytherapy. The five-year survival rate for localized uterine cancer in Turkey reaches up to 92%, highlighting the effectiveness of early detection and personalized treatment plans. These advancements contribute to improved quality of life and outcomes for patients.
Germany is a leading destination for uterine cancer treatment, with numerous certified oncology centers recognized by the German Cancer Society (DKG). Clinics like the Medical Center in Solingen, Asklepios Hospital Barmbek, and Nordwest Clinic offer advanced treatments. The Medical Center in Solingen treats over 60,000 patients annually, while Asklepios Hospital Barmbek provides comprehensive care to over 80,000 patients each year. Nordwest Clinic utilizes technologies such as 3D ultrasound and anticancer vaccines in targeted therapy.
The survival rate for uterine cancer in Germany is among the highest globally, with early-stage treatment success rates exceeding 90%. Latest procedures include robotic-assisted surgery, brachytherapy, immunotherapy, and targeted therapy.
Akademicka Klinika Solingen — wielospecjalistyczny szpital w Niemczech, w TOP najlepszych szpitali w kraju według magazynu Focus.
Specjalizacja — onkologia, neurochirurgia, gastroenterologia, kardiologia i ortopedia.
2 lekarzy kliniki znajduje się na liście polecanych specjalistów w Niemczech według Focus i Guter Rat— profesor Wolfgang Schwenk, chirurg jamy brzusznej, oraz profesor Peter Hering, specjalista w leczeniu nadciśnienia i chorób nerek.
Rocznie do Solingen zgłasza się ponad 60 000 pacjentów.
Spain is a leading destination for uterine cancer treatment, with clinics accredited by the Joint Commission International. Leading hospitals like Centro Médico Teknon, Quironsalud Madrid, and Hospital Quiron Barcelona offer advanced treatments, including robotic-assisted surgery, laparoscopic hysterectomy, and advanced radiation therapy. Quiron Barcelona is part of the Baselga Institute of Oncology, enhancing its expertise in cancer care.
Uterine cancer treatment in Spain shows high success rates, particularly for early-stage cases. The five-year survival rate for uterine cancer can reach up to 90% when diagnosed and treated promptly. This reflects the effectiveness of Spain's advanced treatment modalities and personalized care approaches.
Poland is emerging as a significant player in uterine cancer treatment, with institutions like the University Hospital in Krakow, Institute of Cybernetic Surgery Cyberknife, and Medical Centre ENEL-MED leading the way. The University Hospital in Krakow is well-equipped with advanced technology. The Institute of Cybernetic Surgery Cyberknife, supported by the European Regional Development Fund, specializes in cancer treatment. Medical Centre ENEL-MED offers comprehensive care, including surgery and rehabilitation.
The survival rate for uterine cancer in Poland is promising, with early-stage treatment success rates significantly high due to precise diagnostics and personalized treatment plans. The latest procedures include robotic-assisted surgery, laparoscopic hysterectomy, targeted therapy, and brachytherapy. According to the Center for Quality Monitoring in Health Protection, Polish institutions are continually improving their services, reflecting the dedication and expertise of medical professionals.
Israel is a leading destination for uterine cancer treatment, with Sourasky Medical Center (Ichilov), Assuta Medical Center, and Hadassah Medical Center at the forefront. Sourasky Medical Center, accredited by the Joint Commission International, boasts a 90% success rate in oncology treatments. Assuta Medical Center is recognized for its patient-centered care and advanced surgical techniques.
Israel's high uterine cancer survival rates are attributed to advanced technologies and personalized treatments. Procedures like robotic-assisted surgery, targeted therapy, immunotherapy, and HIPEC are commonly used. The five-year survival rate for uterine cancer in Israel is approximately 84%, reflecting the effectiveness of these comprehensive treatment approaches.